기도 양압기 시장 보고서 : 제품 유형, 최종사용자, 지역별(2025-2033년)

The global positive airway pressure devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.14% during 2025-2033. The increasing occurrence of depression, hypertension, diabetes, and heart disorders is stimulating the market.

Positive Airway Pressure Devices Market Trends:

Increasing Prevalence of Sleep Apnea

The rising awareness towards the occurrence of sleep disorders is escalating the demand for diagnosis and treatment, which is catalyzing the market. For example, in May 2024, Dutch healthcare company Philips launched continuous positive airway pressure (CPAP) therapy devices that are used to treat sleep apnea. Moreover, in India, Philips offered support through a hotline and website. This is contributing to the positive airway pressure devices market outlook.

Rising Technological Advancements

Continuous innovations, which enhance treatment efficacy, automatically adjust pressure levels based on the user's needs, elevate patient comfort, etc., are stimulating the market. Furthermore, advances in mask design with features aimed at minimizing noise are also propelling the overall market. In July 2024, Varon, previously known for oxygen concentrator solutions, introduced its new Sunnygrand series that offer effective and comfortable treatment for sleep apnea patients, integrating with doctors' prescribed settings and therapy plans. It also supports ongoing monitoring and adjustments by healthcare professionals. As per the positive airway pressure devices market analysis report, it is acting as a significant growth-inducing factor.

Escalating Demand for Home Healthcare

With the inflating healthcare costs and the increasing emphasis on patient-centric care, more individuals are opting for home-based management of sleep apnea. It allows healthcare providers to monitor and adjust treatment remotely. In March 2024, React Health developed a travel CPAP called the Luna TravelPAP. It is a small, lightweight positive airway pressure device with CPAP and AutoCPAP modes. Additionally, it has supply reminders, an optional carrying case, a light ring indicator, etc.

Global Positive Airway Pressure Devices Industry Segmentation:

Breakup by Product Type:

• Automatic Positive Airway Pressure (APAP) Devices
• Continuous Positive Airway Pressure (CPAP) Devices
• Bi-level Positive Airway Pressure (BiPAP) Devices

Continuous positive airway pressure (CPAP) devices dominate the total positive airway pressure devices market share

The inflating requirement for enhanced user comfort and treatment efficacy is driving the segment's growth. For example, the development of ResMed's AirSense 11, which features an auto-adjusting algorithm and integrated connectivity that enables personalized therapy adjustments and remote monitoring.

Breakup by End User:

• Hospitals and Sleep Labs
• Home Care
• Others

Hospitals and sleep labs hold the majority of the global positive airway pressure devices market demand

In these clinical settings, advanced PAP devices are utilized to ensure accurate diagnosis and effective treatment. For example, the Philips Respironics DreamStation BiPAP AutoSV is frequently adopted in hospitals for patients with complex sleep apnea, owing to its ability to adjust pressure levels automatically based on the patient's needs. This is expanding the positive airway pressure devices market forecast report.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America exhibits a clear dominance in the market

The positive airway pressure devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The widespread prevalence of sleep apnea and other respiratory disorders is augmenting the positive airway pressure devices market outlook report in North America. In February 2024, ResMed introduced its AirCurve 11 series bilevel positive airway pressure devices in the U.S. It is designed to help providers treat sleep apnea while patients start and stay on therapy.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• 3B Medical Inc.
• Apex Medical Corp.
• Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
• Drive Devilbiss Healthcare (Drive International LLC)
• Fisher & Paykel Healthcare Limited
• Koninklijke Philips N.V.
• Resmed Inc.
• Smiths Group Plc
• Somnetics International Inc.
• Vyaire Medical Inc.

Key Questions Answered in This Report

• 1.What was the size of the global positive airway pressure devices market in 2024?
• 2.What is the expected growth rate of the global positive airway pressure devices market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global positive airway pressure devices market?
• 4.What are the key factors driving the global positive airway pressure devices market?
• 5.What is the breakup of the global positive airway pressure devices market based on the product type?
• 6.What is the breakup of the global positive airway pressure devices market based on the end user?
• 7.What are the key regions in the global positive airway pressure devices market?
• 8.Who are the key players/companies in the global positive airway pressure devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Positive Airway Pressure Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Automatic Positive Airway Pressure (APAP) Devices
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Continuous Positive Airway Pressure (CPAP) Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Bi-level Positive Airway Pressure (BiPAP) Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals and Sleep Labs
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Home Care
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 3B Medical Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Apex Medical Corp.
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
  • 13.3.3 Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
  • 13.3.4 Drive Devilbiss Healthcare (Drive International LLC)
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
  • 13.3.5 Fisher & Paykel Healthcare Limited
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Koninklijke Philips N.V.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Resmed Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Smiths Group Plc
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Somnetics International Inc.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
  • 13.3.10 Vyaire Medical Inc.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio